Katherine Eade

Director/Board Member presso HARVARD BIOSCIENCE, INC.

Patrimonio netto: 962 459 $ in data 31/03/2024

50 anni

100 relazioni

Health Technology

Consumer Services

Electronic Technology

Profilo

Katherine A.
Eade is an Independent Director at Harvard Bioscience, Inc. She previously worked as the Director-M&A Law at Corning, Inc. from 2009 to 2018.
She also served as an Independent Director at Vaxxinity, Inc. in 2023.
In addition, Katherine was the Deputy General Counsel at La-Z-Boy, Inc. from 2018 to 2019 and the Vice President-Strategic Commercial Affairs at Align Technology, Inc. from 2019 to 2020.
Prior to that, she worked as an Attorney at Cleary Gottlieb Steen & Hamilton LLP from 2001 to 2009.
Katherine also served as the General Counsel at Checkmate Pharmaceuticals, Inc. from 2020 to 2022.
She has a background in law, having obtained her undergraduate degree from Cornell University and her graduate degree from Harvard Law School.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
HARVARD BIOSCIENCE, INC. 0.52%	22/05/2023	226 995 ( 0.52% )	962 459 $	31/03/2024

Posizioni attive di Katherine Eade

Società	Posizione	Inizio
HARVARD BIOSCIENCE, INC.	Director/Board Member	24/10/2017

Tutte le posizioni attive di Katherine Eade

Precedenti posizioni note di Katherine Eade

Società	Posizione	Fine
VAXXINITY, INC.	Director/Board Member	30/11/2023
CHECKMATE PHARMACEUTICALS, INC.	General Counsel	01/05/2022
ALIGN TECHNOLOGY, INC.	Corporate Officer/Principal	01/07/2020
LA-Z-BOY INCORPORATED	Corporate Officer/Principal	01/01/2019
CORNING INCORPORATED	Corporate Officer/Principal	01/01/2018

Vedi nel dettaglio l'esperienza di Katherine Eade

Formazione di Katherine Eade

Cornell University	Undergraduate Degree
Harvard Law School	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Katherine Eade

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	6
CORNING INCORPORATED	Electronic Technology
LA-Z-BOY INCORPORATED	Consumer Durables
HARVARD BIOSCIENCE, INC.	Health Technology
ALIGN TECHNOLOGY, INC.	Health Technology
STANDARD BIOTOOLS INC.	Health Technology
VAXXINITY, INC.	Health Technology

Aziende private	2
Cleary Gottlieb Steen & Hamilton LLP Cleary Gottlieb Steen & Hamilton LLP Miscellaneous Commercial ServicesCommercial Services Cleary Gottlieb Steen & Hamilton LLP is an international law firm that provides legal services to clients. The company serves multinational corporations, international financial institutions, sovereign governments and its agencies and domestic corporations and financial institutions. The company was founded by George Cleary, Leo Gottlieb, Henry Friendly, Mel Steen, Hugh Cox, Fowler Hamilton and George Ball in 1946 and it is headquartered in New York, NY.	Commercial Services
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology

Aziende private